Clinical trial
Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast Cancer
NCT00080860
Study timeline
Study start (unknown)2004-02-01Date precision: month
Registry last updated2012-03-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
microarray analysisGENETIC
conventional surgeryPROCEDURE
lymphangiographyPROCEDURE
radionuclide imagingPROCEDURE
sentinel lymph node biopsyPROCEDURE
technetium Tc 99m sulfur colloidRADIATION
Sponsors & collaborators
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00080860 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.